Position history for BlackRock, Inc.'s holdings in MONTE ROSA THERAPEUTICS INC
BlackRock, Inc. holds 4.2M shares of GLUE (MONTE ROSA THERAPEUTICS INC), worth $65.6M as of 2025-Q4. The position was increased (++9.6% shares). GLUE represents 0.0% of BlackRock, Inc.'s portfolio.
Current Value
$65.6M
Current Shares
4.2M
Total Value Change
+$38.9M
Total Shares Change
+340,997
Other major holders of GLUE: BAKER BROS. ADVISORS LP, Avoro Capital Advisors LLC, VANGUARD GROUP INC
Increased |
| 4.2M |
+9.6% |
| $65.6M |
| 0.0% |
| $15.97 |
32 |
| 2025-Q3 | Decreased | 3.8M | -0.8% | $28.3M | 0.0% | $7.31 | 0 |
| 2025-Q2 | Increased | 3.8M | +2.1% | $17.3M | 0.0% | $4.60 | 29 |
| 2025-Q1 | Decreased | 3.8M | -1.9% | $17.5M | 0.0% | $5.10 | 0 |
| 2024-Q4 | New | 3.8M | - | $26.7M | 0.0% | $7.02 | 40 |